Skip to main content

 Scientific publications

Predictive factors for cancer-associated thrombosis in a large retrospective single-center study.

Authors : Haltout J, Awada A, Paesmans M, Moreau M, Klastersky J, Machiels G, Ignatiadis M, Kotecki N
Year : 2019
Journal : Support Care Cancer
Volume : 27
Pages : 1163-1170

Supportive care in the era of immunotherapies for advanced non-small-cell lung cancer.

Authors : Awada G, Klastersky J
Year : 2018
Journal : Curr Opin Oncol
Volume : 30(2)
Pages : 98-104

Development of the Multi-Dimensional Analysis of Patient Outcome Predictions (MD.POP) during medical encounters.

Authors : Ménard C, Libert Y, Canivet D, Van Achte L, Farvacques C, Liénard A, Merckaert I, Reynaert C, Slachmuylder JL, Durieux JF, Klastersky J, Razavi D
Year : 2018
Journal : Patient Educ Couns
Volume : 101(1)
Pages : 52-58

Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events.

Authors : Bond TC, Szabo E, Gabriel S, Klastersky J, Tomey O, Mueller U, Schwartzberg L, Tang B
Year : 2018
Journal : J Oncol Pharm Pract
Volume : 24(6)
Pages : 412-423

Supportive care in cancer: quo vadis.

Authors : Klastersky J
Year : 2018
Journal : Curr Opin Oncol
Volume : 30(4)
Pages : 203-204

Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinati

Authors : Rapoport BL, Aapro M, Paesmans M, van Eeden R, Smit T, Krendyukov A, Klastersky J
Year : 2018
Journal : BMC Cancer
Volume : 18
Pages : 917

The concept of oligometastases in colorectal cancer: from the clinical evidences to new therapeutic strategies.

Authors : Massaut E, Bohlok A, Lucidi V, Hendlisz A, Klastersky J, Donckier V
Year : 2018
Journal : Curr Opin Oncol
Volume : 30(4)
Pages : 262-268

Predictors of physicians' communication performance in a decision-making encounter with a simulated advanced-stage cancer patient: A longitudinal study.

Authors : Libert Y, Canivet D, Ménard C, Van Achte L, Farvacques C, Merckaert I, Liénard A, Klastersky J, Reynaert C, Slachmuylder JL, Durieux JF, Delvaux N, Razavi D
Year : 2017
Journal : Patient Educ Couns
Volume : 100(9)
Pages : 1672-9

Intravenous iron therapy for anemic cancer patients: a review of recently published clinical studies.

Authors : Lebrun F, Klastersky J, Levacq D, Wissam Y, Paesmans M
Year : 2017
Journal : Support Care Cancer
Volume : 25(7)
Pages : 2313-2319

Physical long-term side-effects in young adult cancer survivors: germ cell tumors model.

Authors : Kourie HR, Klastersky J
Year : 2017
Journal : Curr Opin Oncol
Volume : 29(4)
Pages : 229-234

Concurrent driver mutations/rearrangements in non-small-cell lung cancer.

Authors : Tabchi S, Kourie HR, Klastersky J
Year : 2017
Journal : Curr Opin Oncol
Volume : 29(2)
Pages : 118-22

Old age: An extra risk for febrile neutropenia?

Authors : Klastersky J, Dal Lago L
Year : 2017
Journal : J Geriatr Oncol
Volume : 8(2)
Pages : 84-85

Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data.

Authors : Lalami Y, Klastersky J
Year : 2017
Journal : Crit Rev Oncol Hematol
Volume : 120
Pages : 163-179

Supportive care for patients undergoing immunotherapy.

Authors : Rapoport BL, van Eeden R, Sibaud V, Epstein JB, Klastersky J, Aapro M, Moodley D
Year : 2017
Journal : Support Care Cancer
Volume : 25(10)
Pages : 3017-3030

Long-term survival after cancer: at what cost?

Authors : Klastersky J
Year : 2017
Journal : Curr Opin Oncol
Volume : 29
Pages : 227-228

Clinical research in febrile neutropenia in cancer patients:Past achievements and perspectives for the future

Authors : Klastersky J, Paesmans M, Aoun M, Georgala A, Loizidou A, Lalami Y, Dal Lago L
Year : 2016
Journal : World J Clin Infect Dis
Volume : 6(3)
Pages : 37-60

Faut-il réévaluer les indications pour l’utilisation des facteurs stimulant la granulopoïèse en fonction des comorbidités présentées par les patients?

Authors : Klastersky J, Paesmans M
Year : 2016
Journal : Onco-Hémato
Volume : -
Pages : 4 pages

Biomarkers for adverse events associated with immune checkpoint inhibitors.

Authors : Kourie HR, Paesmans M, Klastersky J
Year : 2016
Journal : Biomark Med
Volume : 10
Pages : 1029-31

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.

Authors : Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, Herrstedt J
Year : 2016
Journal : Ann Oncol
Volume : 27
Pages : v111-v118

The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013."

Authors : Rapoport B, Klastersky J, Raftopoulos H, Freifeld A, Aoun M, Zinner SH, Rolston KV
Year : 2016
Journal : Support Care Cancer
Volume : 24(7)
Pages : 2819-26